2-([1,1'-Biphenyl]-4-yl)-1-phenylethanone, 95.0%, 250mg

ethyl 5-(4-methoxyphenyl)-1,3-oxazole-2-carboxylate, 95.0%, 500mg

6-Nitroimidazo[1,2-a]pyridine, 97.0%, 100g

4-(4-(tert-Butyl)phenyl)-2-(7-ethylindol-3-yl)-4-oxobutanoic acid, 98%, 10g

4-(aminomethyl)-N,N-dimethyl-1,3-thiazol-2-amine dihydrochloride, 95.0%, 1g

4-Chloro-6H,7H,8H-pyrimido[5,4-b][1,4]oxazine, 98+%, 1g

tert-Butyl 4-hydroxy-4-(1H-imidazol-2-yl)piperidine-1-carboxylate, 97%, 1g

2-(Isopropylamino)cyclohexan-1-ol, 98%, 10g

1,2,3,4,5,6-Hexahydro-1,5-methano-pyrido[1,2- a ][1,5]diazocin-8-one, 250mg

2,4,6-Tribromobenzoic acid, 95.0%, 10g

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-chlorobenzyl)pyrrolidine-2-carboxylic acid, 95.0%, 500mg

anti-Uroplakin III monoclonale murino, AU1, 1 ml

(2E)-1-(4-bromophenyl)-3-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g